ACOUSIA THERAPEUTICS
Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany. Acousia has experience and expertise in identifying and developing small molecule drug candidates for the treatment of hearing loss. Sensory hair cells are the key cells for hearing in the inner ear. Acousia`s approach will help to replace lost hair cells by cellular regeneration originating from supporting cells. ASpherecousia is developing drugs for local application, which will restore hearing in patients who have lost their hearing ability induced by various reasons, e.g. noise trauma, treatment with ototoxic drugs or sudden deafness. In addition, these therapies will have the potential to treat the age-related decrease in hearing capacity.
ACOUSIA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
Tübingen, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.acousia.com
Total Employee:
1+
Status:
Active
Total Funding:
12.5 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon WordPress Organization Schema Sitelinks Search Box Person Schema Vimeo WP Rocket
Similar Organizations
AMSilk
AMSilk produces and distributes high-quality silk biopolymers.
Cinclus Pharma
Cinclus Pharma is a research based biotech company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Cygnal Therapeutics
Cygnal Therapeutics is a biotechnology company
GetSteps
GetSteps are into custom orthopedic insole market by providing tailored insole.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Kamleon
Kamleon is a science-based early-stage company.
ONK Therapeutics
ONK Therapeutics is an innovative cell therapy organisation.
PeproMene Bio
PeproMene Bio is a virtual, privately funded biotech company .
RadioMedix
RadioMedix, Inc. is a privately held biotechnology company
Current Employees Featured
Hubert Löwenheim Founder @ Acousia Therapeutics
Founder
Michael Bös CSO @ Acousia Therapeutics
CSO
Tim Boelke CEO, CMO @ Acousia Therapeutics
CEO, CMO
Karl-Heinz Wiesmüller CEO and Co-founder @ Acousia Therapeutics
CEO and Co-founder
Founder
Investors List
Esperante Ventures
Esperante Ventures investment in Venture Round - Acousia Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series B - Acousia Therapeutics
LBBW VC
LBBW VC investment in Series B - Acousia Therapeutics
Creathor Ventures
Creathor Ventures investment in Series B - Acousia Therapeutics
Bregua
Bregua investment in Series B - Acousia Therapeutics
KfW
KfW investment in Series B - Acousia Therapeutics
Axxam
Axxam investment in Series A - Acousia Therapeutics
KfW
KfW investment in Series A - Acousia Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series A - Acousia Therapeutics
Official Site Inspections
http://www.acousia.com Semrush global rank: 14.83 M Semrush visits lastest month: 36
- Host name: r29526.agenturserver.it
- IP address: 185.243.133.181
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Acousia Therapeutics"
About › Acousia Therapeutics GmbH
Jul 30, 2020 Acousia has several exclusive co-operations with leading institutions in the field of hearing loss research and development. We work closely with UKT Translational Hearing Research Group of Tuebingen University, …See details»
Acousia Therapeutics - Crunchbase Company Profile & Funding
Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany. Acousia has experience and expertise in identifying and developing small molecule drug …See details»
Acousia Therapeutics | Boehringer Ingelheim Venture Fund
Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany. It is dedicated to identifying small molecules for treating hearing loss, by restoring sensory hair …See details»
Acousia Therapeutics GmbH - LinkedIn
Acousia is a pioneer of novel medicines. Founded in 2012, the company’s experienced and entrepreneurial management team is committed to combating hearing loss. Thanks to its …See details»
Acousia Therapeutics - Company Profile - Tracxn
Feb 8, 2025 The company Acousia has announced the enrollment of its first patient in the Phase 2 PROHEAR-Study for hearing loss.smebulletin.com • Feb 15, 2024 • Acousia Therapeutics …See details»
Acousia Therapeutics - Craft
Acousia Therapeutics is a biotech company working to identify small molecules for treatment of hearing loss. The Company develops a technology which will help to replace lost hair cells by …See details»
Acousia Therapeutics 2025 Company Profile: Valuation, Funding ...
Acousia Therapeutics General Information Description. Developer of regenerative drugs designed to treat acute forms of hearing loss. The company's drugs replace lost hair cells by stimulating …See details»
Acousia Therapeutics - VentureRadar
Acousia Therapeutics GmbH is a privately held biotech company based in Tübingen, Germany, dedicated to identify small molecules for an innovative treatment of hearing loss. The new …See details»
Acousia Therapeutics - Org chart - The Org
Explore Acousia Therapeutics' organizational chart. Discover current team members including executives, board members, and advisors.See details»
Acousia Therapeutics GmbH - Drug pipelines, Patents, Clinical …
May 7, 2025 Acousia Therapeutics develops drugs for both local and systemic administration. Contact Tim Boelke, M.D. [email protected] About Esperante Ventures Esperante is a …See details»
News › Acousia Therapeutics GmbH
Apr 29, 2025 Acousia Therapeutics GmbH will be presenting data on the company’s clinical stage, first-in-class lead candidate ACOU085 at the Hanson Wade 2nd Inner Ear Therapeutics …See details»
Acousia Therapeutics (Acousia Therapeutics GmbH) - startbase.com
Recent mentions of Acousia Therapeutics in podcasts & videos: Jobs at Acousia Therapeutics: Other Startups nearby. Invisibel. Startup 2020 Tübingen. Invisibel. Automated helm for …See details»
Hearing Loss Company Acousia Therapeutics Green Lighted for
TÜBINGEN, Germany, Oct. 9, 2023 /PRNewswire/ --acousia Therapeutics GmbH a pioneer clinical-stage biotech company focused on the development of novel drug therapies for the …See details»
Home › Acousia Therapeutics GmbH
Jul 30, 2020 Geneva: World Health Organization; 2021. Dementia prevention, intervention, and care: 2020 report by the ... Acousia is developing a series of small molecule drug candidates …See details»
Acousia Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Access exclusive financial …See details»
Programs › Acousia Therapeutics GmbH
Acousia develops small molecule drug candidates as a first-line treatment for patients in need of immediate, high, and localized drug exposure to help preserve their hearing. Following the …See details»
Acousia Therapeutics receives EUR 2.5 million to develop …
Dec 14, 2016 These programs will be further progressed by Acousia to generate clinical candidates to be developed subsequently to demonstrate clinical proof of concept. ... Axxam …See details»
Approach › Acousia Therapeutics GmbH
Jul 30, 2020 Geneva: World Health Organization; 2021. Dementia prevention, intervention, ... Acousia develops small molecule drugs, which are designed to affect validated targets …See details»
Hearing loss company Acousia announces first patient enrolled in …
Feb 15, 2024 Acousia is focused on the development of proprietary drug candidates, which are designed to affect the sensory outer hair cells (OHC) in the cochlea of the inner ear. The …See details»
Shop | Acousha Collectibles
1846 Braided Hair Large Cent PCGS AU55 (Medium Date) Out of stock. Quick ViewSee details»